News

31. Berkshire Sterile Expands Analytical Testing And Development Services 12/19/2022

    Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand their testing and development capabilities.

32. Kindeva And Meridian Combine: Create Leading Drug-Device Combination Product CDMO 12/13/2022

    The combination has created a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products. The combination will operate under the Kindeva name, with Meridian operating as, “Meridian Medical Technologies, a Kindeva Company”.

33. Gov. Whitmer Announces Pfizer Investing $750M To Expand U.S. Sterile Injectable Facility, Create 300 Jobs 12/5/2022

    Today Governor Gretchen Whitmer announced that Pfizer Inc. will be investing $750M in its Kalamazoo, Michigan facility, expanding production and creating 300 good-paying jobs. This investment aims to establish the facility as one of the most technologically advanced in the world and continue to ensure the uninterrupted supply of Pfizer medicines and vaccines.

34. Datwyler Adds Steam Sterilization Option For Ready-To-Use Components For Injectable Drugs 12/1/2022

    Datwyler, a leading provider of high-quality, system-critical elastomer components, announces the launch of Steam Sterilization for Ready-to-Use components. This service is applicable to non-coated and coated solutions like OmniFlex® stoppers for vials and NeoFlexä plungers for prefilled syringes and cartridges. As part of the company’s “Quality First” approach to designing and producing these packaging components, Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of 2 years after steam sterilization.

35. WuXi STA Launches Another Parenteral Formulation Manufacturing Line At Wuxi City Site 12/1/2022

    WuXi STA, a subsidiary of WuXi AppTec, today announced a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units.

36. Recipharm Invests In Its Single Dose Nasal Platform Capabilities 11/30/2022

    Recipharm, a global contract development and manufacturing organisation (CDMO), has announced that it is expanding its capabilities for its proprietary Unidose Xtra (single dose) nasal delivery platform.

37. Kindeva Drug Delivery And Meridian Medical Technologies To Combine 11/15/2022

    Kindeva Drug Delivery announced that it will combine with Meridian Medical Technologies. The combination will create a leading global drug-device combination product CDMO. Kindeva and Meridian will continue to operate independently until closing.

38. Bridgewest Group Inks Deal With Pfizer To Acquire Injectable Manufacturing Plant In Western Australia 11/11/2022

    Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, is expanding its portfolio. Today, Bridgewest Group has announced the signing of a definitive agreement to purchase the sterile injectable manufacturing facility of Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc.

39. CMO Berkshire Sterile Manufacturing To Reveal New Isolator-Based Aseptic Filling Line November 16th 11/9/2022

    Fill Finish CMO, Berkshire Sterile Manufacturing (BSM), will reveal its new, fully automated, 100% isolator-based filling line in a webinar on November 16th at 1PM EST.

40. Aptar Pharma Announces Collaboration With TFF Pharmaceuticals 11/7/2022

    Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced a collaboration with TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform.